GlassScriptPhysician profile
Joy M Miedema
NPI 1225319676
$1,234.30
in general payments reported to CMS, 2019-2025
19 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $492 · 2023: $101 · 2024: $88.30 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $170.73 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Amarin Pharma, INC. | $166.61 | 2021-2022 | |
| Novo Nordisk INC | $153.66 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $127.31 | 2022-2023 | |
| Glaxosmithkline, LLC. | $109.58 | 2022-2025 | Arexvy, Shingrix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $92.16 | 2021-2022 | |
| Astellas Pharma US INC | $66.66 | 2021-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $58.66 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.18 | 2021 | |
| Exact Sciences Corporation | $36.99 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $33.46 | 2022 | |
| Linus Health, INC. | $26.48 | 2023 | |
| Dexcom, INC. | $24.23 | 2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $23.97 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.17 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $20.01 | 2025 | Voquezna |
| Bausch Health US, LLC | $16.77 | 2021 | |
| Pfizer INC. | $15.98 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Miedema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.